Feedback / Questions
CBL-514 - Caliway Biopharmaceuticals
https://www.prnewswire.com/news-releases/caliway-announces-fda-clearance-of-ind-application-for-cbl-514-to-proceed-with-supreme-01-the-first-global-pivotal-phase-3-study-for-reducing-abdominal-subcutaneous-fat-302514808.html
 
Jul 28, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious